Enhanced Efficacy of Carvedilol by Utilization of Solid Dispersion and Other Novel Strategies : A Review
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Carvedilol is classified as a second class drug of Biopharmaceutical classification system (BCS), and it is an excellent beta blocker and vasodilating agent. It is used in a diverse range of disease states. Despite having tremendous advantages, the drug cannot be used effectively and productively due to aquaphobicity and poor bioavailability. To overcome this limitation, numerous novel approaches and tactics have been introduced over the past few years, such as Selfmicro emulsifying drug delivery systems (SMEDDS), nanoparticles, solid dispersions and liposomal drug delivery. The present review aims to accentuate the role of solid dispersion in improving the dissolution profile and aqua solubility of carvedilol and also to emphasize other novel formulations of carvedilol proposed to prevail the limitations of carvedilol. Solid dispersion and other novel approaches were found to play a significant role in overcoming the drawbacks of carvedilol, among which solid dispersion is the most feasible and effective approach being used worldwide. Reduced particle size, more wettability, and large surface area are obtained by the implementation of solid dispersion technique, hence improving carvedilol solubility and bioavailability.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Cardiovascular & hematological disorders drug targets - 23(2023), 3 vom: 29., Seite 141-156 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rao, Lakshita [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0K47UL67F2 |
|---|
| Anmerkungen: |
Date Completed 03.01.2024 Date Revised 20.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/011871529X247622231101075854 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364452722 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364452722 | ||
| 003 | DE-627 | ||
| 005 | 20240320233636.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/011871529X247622231101075854 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM364452722 | ||
| 035 | |a (NLM)37953616 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rao, Lakshita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced Efficacy of Carvedilol by Utilization of Solid Dispersion and Other Novel Strategies |b A Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Carvedilol is classified as a second class drug of Biopharmaceutical classification system (BCS), and it is an excellent beta blocker and vasodilating agent. It is used in a diverse range of disease states. Despite having tremendous advantages, the drug cannot be used effectively and productively due to aquaphobicity and poor bioavailability. To overcome this limitation, numerous novel approaches and tactics have been introduced over the past few years, such as Selfmicro emulsifying drug delivery systems (SMEDDS), nanoparticles, solid dispersions and liposomal drug delivery. The present review aims to accentuate the role of solid dispersion in improving the dissolution profile and aqua solubility of carvedilol and also to emphasize other novel formulations of carvedilol proposed to prevail the limitations of carvedilol. Solid dispersion and other novel approaches were found to play a significant role in overcoming the drawbacks of carvedilol, among which solid dispersion is the most feasible and effective approach being used worldwide. Reduced particle size, more wettability, and large surface area are obtained by the implementation of solid dispersion technique, hence improving carvedilol solubility and bioavailability | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Carvedilol | |
| 650 | 4 | |a aqueous solubility | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a dissolution rate | |
| 650 | 4 | |a novel formulations. | |
| 650 | 4 | |a solid dispersions | |
| 650 | 7 | |a Carvedilol |2 NLM | |
| 650 | 7 | |a 0K47UL67F2 |2 NLM | |
| 700 | 1 | |a Bhardwaj, Bigul Yogeshver |e verfasserin |4 aut | |
| 700 | 1 | |a Chugh, Mahek |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Ashish |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Rashmi |e verfasserin |4 aut | |
| 700 | 1 | |a Minocha, Neha |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Parijat |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular & hematological disorders drug targets |d 2006 |g 23(2023), 3 vom: 29., Seite 141-156 |w (DE-627)NLM163039259 |x 2212-4063 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:3 |g day:29 |g pages:141-156 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/011871529X247622231101075854 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 3 |b 29 |h 141-156 | ||